BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3814732)

  • 21. Selection designs for pilot studies based on survival.
    Liu PY; Dahlberg S; Crowley J
    Biometrics; 1993 Jun; 49(2):391-8. PubMed ID: 8369375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased power to detect gene-environment interaction using siblings controls.
    Andrieu N; Dondon MG; Goldstein AM
    Ann Epidemiol; 2005 Oct; 15(9):705-11. PubMed ID: 16157257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sample size determination for logistic regression revisited.
    Demidenko E
    Stat Med; 2007 Aug; 26(18):3385-97. PubMed ID: 17149799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of one-sample two-sided sequential t-tests for application in epidemiological studies.
    van der Tweel I; Kaaks R; van Noord PA
    Stat Med; 1996 Dec; 15(24):2781-95. PubMed ID: 8981686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of experiments with adaptive interim analyses.
    Bauer P; Köhne K
    Biometrics; 1994 Dec; 50(4):1029-41. PubMed ID: 7786985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bayesian semiparametric modeling for matched case-control studies with multiple disease states.
    Sinha S; Mukherjee B; Ghosh M
    Biometrics; 2004 Mar; 60(1):41-9. PubMed ID: 15032772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approximate sample size formulas for the two-sample trimmed mean test with unequal variances.
    Luh WM; Guo JH
    Br J Math Stat Psychol; 2007 May; 60(Pt 1):137-46. PubMed ID: 17535584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interval estimation of the proportion ratio under multiple matching.
    Lui KJ
    Stat Med; 2005 Apr; 24(8):1275-85. PubMed ID: 15565736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimum allocation of treatments for Welch's test in equivalence assessment.
    Dette H; Munk A
    Biometrics; 1997 Sep; 53(3):1143-50. PubMed ID: 9333344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sample sizes for clinical trials with normal data.
    Julious SA
    Stat Med; 2004 Jun; 23(12):1921-86. PubMed ID: 15195324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sample size and the probability of a successful trial.
    Chuang-Stein C
    Pharm Stat; 2006; 5(4):305-9. PubMed ID: 17128428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sample size for testing and estimating the difference between two paired and unpaired proportions: a 'two-step' procedure combining power and the probability of obtaining a precise estimate.
    Cesana BM
    Stat Med; 2004 Aug; 23(15):2359-73. PubMed ID: 15273953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On pooling across strata when frequency matching has been followed in a cohort study.
    Weinberg CR
    Biometrics; 1985 Mar; 41(1):117-27. PubMed ID: 4005370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of two methods for adaptive interim analyses in clinical trials.
    Wassmer G
    Biometrics; 1998 Jun; 54(2):696-705. PubMed ID: 9629649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flexible two-stage design with sample size reassessment for survival trials.
    Desseaux K; Porcher R
    Stat Med; 2007 Nov; 26(27):5002-13. PubMed ID: 17577242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approaches for calculating power for case-cohort studies.
    Kim MY; Xue X; Du Y
    Biometrics; 2006 Sep; 62(3):929-33; discussion 933. PubMed ID: 16984338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishing equivalence of two treatments and sample size requirements in matched-pairs design.
    Nam JM
    Biometrics; 1997 Dec; 53(4):1422-30. PubMed ID: 9423257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Approximate simultaneous confidence intervals for multiple contrasts of binomial proportions.
    Schaarschmidt F; Sill M; Hothorn LA
    Biom J; 2008 Oct; 50(5):782-92. PubMed ID: 18932137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential gain in precision and power by matching on strong risk factors in case-control studies: the example of laryngeal cancer.
    Stürmer T; Brenner H
    J Epidemiol Biostat; 2000; 5(2):125-31. PubMed ID: 10890284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K; Boucher H; Tsiatis AA
    Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.